Jeffrey Jacot

Dr. Jeffrey Jacot

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Biophysical Journal
Verified
Journal Article
Closed access
PDF file
JJJeffrey Jacot
Jeffrey Jacot
AMAndrew D. McCulloch
Andrew D. McCulloch
JOJeffrey H. Omens
Jeffrey H. Omens

1 January 2010 in Journal of Biomechanics
Verified
Journal Article
Closed access
JJJeffrey Jacot
Jeffrey Jacot
JMJody C. Martin
Jody C. Martin
DHDarlene L. Hunt
Darlene L. Hunt

24 January 2007 in Journal of Neural Engineering
Verified
Journal Article
Closed access
Jennie LeachJennie Leach
Jennie Leach
XBXin Q Brown
Xin Q Brown
JJJeffrey Jacot
Jeffrey Jacot
PDPaul A DiMilla
Paul A DiMilla
JWJoyce Y Wong
Joyce Y Wong
Rationally designed matrices for nerve tissue engineering and encapsulated cell therapies critically rely on a comprehensive understanding of neural response to biochemical as well as biophysical cues. Whereas biochemical cues are established mediators of neuronal behavior (e.g., outgrowth), physical cues such as substrate stiffness have only recently been recognized to influence cell behavior. In this work, we examine the response of PC12 neurites to substrate stiffness. We quantified and controlled fibronectin density on the substrates and measured multiple neurite behaviors (e.g., growth, branching, neurites per cell, per cent cells expressing neurites) in a large sample population. We found that PC12 neurons display a threshold response to substrate stiffness. On the softest substrates tested (shear modulus approximately 10 Pa), neurites were relatively few, short in length and unbranched. On stiffer substrates (shear modulus approximately 10(2)-10(4) Pa), neurites were longer and more branched and a greater percentage of cells expressed neurites; significant differences in these measures were not found on substrates with a shear modulus >10(2) Pa. Based on these data and comparisons with published neurobiology and neuroengineering reports of neurite mechanotransduction, we hypothesize that results from studies of neuronal response to compliant substrates are cell-type dependent and sensitive to ligand density, sample size and the range of stiffness investigated.

29 September 2014 in ACS Nano
Verified
Journal Article
Open access
SPSeokwon Pok
Seokwon Pok
FVFlavia Vitale
Flavia Vitale
SEShannon L. Eichmann
Shannon L. Eichmann
OBOmar M. Benavides
Omar M. Benavides
MPMatteo Pasquali
Matteo Pasquali
JJJeffrey Jacot
Jeffrey Jacot
The major limitation of current engineered myocardial patches for the repair of heart defects is that insulating polymeric scaffold walls hinder the transfer of electrical signals between cardiomyocytes. This loss in signal transduction results in arrhythmias when the scaffolds are implanted. We report that small, subtoxic concentrations of single-walled carbon nanotubes, on the order of tens of parts per million, incorporated in a gelatin–chitosan hydrogel act as electrical nanobridges between cardiomyocytes, resulting in enhanced electrical coupling, synchronous beating, and cardiomyocyte function. These engineered tissues achieve excitation conduction velocities similar to native myocardial tissue (22 ± 9 cm/s) and could function as a full-thickness patch for several cardiovascular defect repair procedures, such as right ventricular outflow track repair for Tetralogy of Fallot, atrial and ventricular septal defect repair, and other cardiac defects, without the risk of inducing cardiac arrhythmias.

8 April 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HKHiroko Kita-Matsuo
Hiroko Kita-Matsuo
MBMaria Barcova
Maria Barcova
NPNatalie Prigozhina
Natalie Prigozhina
NSNathan Salomonis
Nathan Salomonis
KWKaren Wei
Karen Wei
MMMark Mercola
Mark Mercola
Developmental, physiological and tissue engineering studies critical to the development of successful myocardial regeneration therapies require new ways to effectively visualize and isolate large numbers of fluorescently labeled, functional cardiomyocytes. Here we describe methods for the clonal expansion of engineered hESCs and make available a suite of lentiviral vectors for that combine Blasticidin, Neomycin and Puromycin resistance based drug selection of pure populations of stem cells and cardiomyocytes with ubiquitous or lineage-specific promoters that direct expression of fluorescent proteins to visualize and track cardiomyocytes and their progenitors. The phospho-glycerate kinase (PGK) promoter was used to ubiquitously direct expression of histone-2B fused eGFP and mCherry proteins to the nucleus to monitor DNA content and enable tracking of cell migration and lineage. Vectors with T/Brachyury and α-myosin heavy chain (αMHC) promoters targeted fluorescent or drug-resistance proteins to early mesoderm and cardiomyocytes. The drug selection protocol yielded 96% pure cardiomyocytes that could be cultured for over 4 months. Puromycin-selected cardiomyocytes exhibited a gene expression profile similar to that of adult human cardiomyocytes and generated force and action potentials consistent with normal fetal cardiomyocytes, documenting these parameters in hESC-derived cardiomyocytes and validating that the selected cells retained normal differentiation and function. The protocols, vectors and gene expression data comprise tools to enhance cardiomyocyte production for large-scale applications.

1 March 2013 in Acta Biomaterialia
Verified
Journal Article
Closed access
SPSeokwon Pok
Seokwon Pok
JMJackson D. Myers
Jackson D. Myers
Sundar MadihallySundar Madihally
Sundar Madihally
JJJeffrey Jacot
Jeffrey Jacot